Blue Sparkles Websized

Health Technology Innovation Platform

The IHE established its Health Technology Innovation Platform (HTIP) to enhance decision-making efficiency and improve value for money for purchasers of health technology, and to strengthen the ability for technology developers to engage in constructive policy dialogue, demonstrate the value of their technology, and improve their return on investment.

The HTIP facilitates collaboration between innovative pharmaceutical organizations and key public sector stakeholders to collectively define priority policy issues and topics that require evidence generation and productive dialogue to identify solutions to complex challenges. Its mission is to:

  • improve value for money for purchasers of health technology;
  • expedite the development of a pro-innovation ecosystem;
  • strengthen constructive policy dialogues between technology developers and all levels of government, healthcare payers, and healthcare providers; and
  • reduce the risk in value demonstration processes.

The IHE is currently recruiting Platform Partners and will provide robust and focused support for organizations to help each achieve their objectives through:

  • a governance structure comprised of participating multinational enterprises (MNEs) and key pan-Canadian life sciences stakeholders (e.g., health technology assessment [HTA], regulatory, payers), each with an equal voice at the table;
  • joint definition by this group of a limited number of priority topics and issues of focus; and
  • subsequent identification of a multipronged program of work and deliverables that will generate evidence as well as new methodologies and capabilities, and will facilitate dialogue to inform policy and practice provincially and nationally.

The Terms of Reference for the governance of the platform partnership, and the selection and management of priority themes and projects, will be developed and agreed to by the participating organizations once identified.